Notably, cancer-associated truncating mutations that delete a C-terminal region of the BRCA2 protein retain RNAPII interaction but nevertheless diminish PAF1 recruitment to increase RNAPII accumulation and R-loop accrual at PPP sites. This evidence concerns the gene BRCA2 and cancer.